Next-generation obesity drug helps patients lose 28% of body weight: Eli Lilly




Eli Lilly can now seek regulatory approval and potentially launch the next-generation drug in 2027.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending now

Five lesser-known museums to visit in Berlin
Decades after Selma violence spurred Voting Rights Act, organizers worry about its fate
News in pictures | March 9, 2026: The best photos from around the world
Greens beat Merz’s CDU in Germany’s key regional elections: exit poll